Literature DB >> 33222769

Assessment of practices for suspended oral drugs by tablet crushing in pediatric units.

David Nguyen1, Phillipe-Henri Secretan2, Sylvain Auvity3, Fabrice Vidal1, Martine Postaire1, Salvatore Cisternino3, Joël Schlatter4.   

Abstract

The aim of this study was to assess the impact of suspended drug by tablet crushing in our pediatric hospital in term of targeted dose and to identify parameters involved in the potential variability. Four usually crushed pediatric drug substances were selected: amiodarone, warfarin, hydrocortisone and captopril. Each tablet was crushed in a bag using a crusher device. Once crushed, a pre-determined volume of water was added using oral syringes before taking the necessary volume to obtain the targeted drug amount. For each drug, operators among pharmacy technicians and nurses investigated 2 targeted doses (high and low). Each suspension was assayed 3 times using the corresponding validated HPLC procedure. Statistical analysis was performed (GraphPad Prism®) to evaluate the impact of operators, the level of suction in bag, and actual drug doses. To investigate the impact of formulation change on syringe drug content, five generic drugs of amiodarone were selected. Syringes contents were compared using one-way ANOVA. Drug loss in syringe ranged from 8.1% to 54.1%. The drug loss represented 18.9% to 30.5% for amiodarone, 0.1% to 5.5% for captopril, 5.6% to 19.7% for warfarin and 5.0% to 30.7% for hydrocortisone. The comparison of level sampling of suspensions presented significant differences for amiodarone, hydrocortisone, and warfarin. Comparison of operators demonstrated significant difference between pharmacy technician and nurse (p = 0.0251). Finally, comparison of 5 generic drugs for amiodarone showed some statistical difference between the syringes content obtained when using the original medicine as compared to the generics. The physicochemical properties of each drug substance and the formulation of the drug product may both factor that should be considered. As a result, crushing tablets in water for oral administration needs a case by case assessment. Although appropriate pediatric formulations are lacking, suspend the crushed material in a given volume of water should be discouraged and not recommended because far from good practice.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Crushing; Drug dosage; Pediatrics; Suspending; Tablets

Mesh:

Substances:

Year:  2020        PMID: 33222769     DOI: 10.1016/j.ejpb.2020.10.013

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease.

Authors:  Mélanie Hinterlang; Maria Sebti; Camille Cotteret; Fabrice Vidal; Bénédicte Neven; Salvatore Cisternino; Joël Schlatter
Journal:  ScientificWorldJournal       Date:  2022-06-02

Review 2.  3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?-A Scoping Review.

Authors:  Iris Lafeber; Elisabeth J Ruijgrok; Henk-Jan Guchelaar; Kirsten J M Schimmel
Journal:  Pharmaceutics       Date:  2022-02-14       Impact factor: 6.321

3.  Performance of Tablet Splitters, Crushers, and Grinders in Relation to Personalised Medication with Tablets.

Authors:  Herman J Woerdenbag; J Carolina Visser; Marlyn P A M Leferink Op Reinink; Roël R van Orsoy; Anko C Eissens; Paul Hagedoorn; Hilda Dijkstra; Derk P Allersma; Shi W Ng; Oscar S N M Smeets; Henderik W Frijlink
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.